rheumatoid arthritis vaccine (Opexa)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerheumatoid arthritis vaccine (Opexa)
Drug Alias Namerheumatoid arthritis vaccine (PharmaFrontiers)T-cell rheumatoid arthritis vaccine (PharmaFrontiers)
ClassificationVaccines > Application > Therapeutic vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaPending
Originator CompaniesShanghai Academy Of Life Sciences, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAcer Therapeutics IncShanghai Academy Of Life Sciences, Chinese Academy Of Sciences
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A